Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
Attending The 42nd Annual J. P. Morgan Healthcare Conference
Manoj Vyas (CEO – CBCC Global Research) will be attending The 42nd Annual J. P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, during 8 – 11 January 2024, at San Francisco, CA.
For more information on this conference, please visit: https://lnkd.in/eZBPTdbM
For business appointments please email us at: manoj.vyas@cbcc.global
We will be attending below upcoming events:
1. The 42nd Annual J. P. Morgan Healthcare Conference (8 – 11 January 2024, San Francisco, California)
2. Bio Asia 2024 (26 – 28 February 2024, Hyderabad, India)
3. Immuno-Oncology 360 (27 – 29 February 2024, New York)
4. DCAT Week (18 – 21 March 2024, New York)
We will be glad to schedule an appointment with you to discuss your upcoming drug development plan and help you bring the treatment to market faster.
CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION
